ATOS
Price
$0.86
Change
+$0.04 (+4.88%)
Updated
Sep 26 closing price
Capitalization
110.89M
51 days until earnings call
MGNX
Price
$1.73
Change
+$0.08 (+4.85%)
Updated
Sep 26 closing price
Capitalization
109.35M
45 days until earnings call
Interact to see
Advertisement

ATOS vs MGNX

Header iconATOS vs MGNX Comparison
Open Charts ATOS vs MGNXBanner chart's image
Atossa Therapeutics
Price$0.86
Change+$0.04 (+4.88%)
Volume$465.21K
Capitalization110.89M
MacroGenics
Price$1.73
Change+$0.08 (+4.85%)
Volume$515.44K
Capitalization109.35M
ATOS vs MGNX Comparison Chart in %
Loading...
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATOS vs. MGNX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATOS is a StrongBuy and MGNX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (ATOS: $0.86 vs. MGNX: $1.73)
Brand notoriety: ATOS and MGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATOS: 53% vs. MGNX: 65%
Market capitalization -- ATOS: $110.89M vs. MGNX: $109.35M
ATOS [@Biotechnology] is valued at $110.89M. MGNX’s [@Biotechnology] market capitalization is $109.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATOS’s FA Score shows that 1 FA rating(s) are green whileMGNX’s FA Score has 0 green FA rating(s).

  • ATOS’s FA Score: 1 green, 4 red.
  • MGNX’s FA Score: 0 green, 5 red.
According to our system of comparison, ATOS is a better buy in the long-term than MGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATOS’s TA Score shows that 7 TA indicator(s) are bullish while MGNX’s TA Score has 4 bullish TA indicator(s).

  • ATOS’s TA Score: 7 bullish, 3 bearish.
  • MGNX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ATOS is a better buy in the short-term than MGNX.

Price Growth

ATOS (@Biotechnology) experienced а +1.15% price change this week, while MGNX (@Biotechnology) price change was +6.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

ATOS is expected to report earnings on Nov 17, 2025.

MGNX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATOS($111M) and MGNX($109M) have the same market capitalization . ATOS YTD gains are higher at: -9.067 vs. MGNX (-46.769). MGNX has higher annual earnings (EBITDA): -26.91M vs. ATOS (-29.97M). MGNX has more cash in the bank: 176M vs. ATOS (57.9M). ATOS has less debt than MGNX: ATOS (0) vs MGNX (37.2M). MGNX has higher revenues than ATOS: MGNX (164M) vs ATOS (0).
ATOSMGNXATOS / MGNX
Capitalization111M109M102%
EBITDA-29.97M-26.91M111%
Gain YTD-9.067-46.76919%
P/E RatioN/AN/A-
Revenue0164M-
Total Cash57.9M176M33%
Total Debt037.2M-
FUNDAMENTALS RATINGS
ATOS vs MGNX: Fundamental Ratings
ATOS
MGNX
OUTLOOK RATING
1..100
1169
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
80
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
5951
P/E GROWTH RATING
1..100
10094
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATOS's Valuation (21) in the Medical Specialties industry is somewhat better than the same rating for MGNX (80) in the Biotechnology industry. This means that ATOS’s stock grew somewhat faster than MGNX’s over the last 12 months.

ATOS's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as MGNX (100) in the Biotechnology industry. This means that ATOS’s stock grew similarly to MGNX’s over the last 12 months.

ATOS's SMR Rating (97) in the Medical Specialties industry is in the same range as MGNX (98) in the Biotechnology industry. This means that ATOS’s stock grew similarly to MGNX’s over the last 12 months.

MGNX's Price Growth Rating (51) in the Biotechnology industry is in the same range as ATOS (59) in the Medical Specialties industry. This means that MGNX’s stock grew similarly to ATOS’s over the last 12 months.

MGNX's P/E Growth Rating (94) in the Biotechnology industry is in the same range as ATOS (100) in the Medical Specialties industry. This means that MGNX’s stock grew similarly to ATOS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATOSMGNX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 10 days ago
80%
Bullish Trend 10 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 12 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKHSY22.910.42
+1.87%
Sekisui House Ltd.
DIIBF1.130.01
+1.10%
Dorel Industries, Inc.
MUEL412.590.59
+0.14%
Mueller (PAUL) Co.
DCNNF0.03N/A
N/A
QUEST CRITICAL METALS INC.
VLEEY6.22-0.05
-0.73%
Valeo SE

ATOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATOS has been loosely correlated with PDSB. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ATOS jumps, then PDSB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATOS
1D Price
Change %
ATOS100%
+5.12%
PDSB - ATOS
41%
Loosely correlated
-0.97%
KYMR - ATOS
41%
Loosely correlated
+4.68%
NRIX - ATOS
41%
Loosely correlated
+7.20%
MGNX - ATOS
40%
Loosely correlated
+4.85%
XNCR - ATOS
39%
Loosely correlated
+12.00%
More

MGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGNX has been loosely correlated with XNCR. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if MGNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGNX
1D Price
Change %
MGNX100%
+4.85%
XNCR - MGNX
52%
Loosely correlated
+12.00%
RGNX - MGNX
52%
Loosely correlated
+3.10%
CRBU - MGNX
52%
Loosely correlated
+10.36%
FATE - MGNX
50%
Loosely correlated
+3.01%
BEAM - MGNX
50%
Loosely correlated
-0.52%
More